My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 112

    1.

    Canine parvovirus-like particles, a novel nanomaterial for tumor targeting.

    Singh P, Destito G, Schneemann A, Manchester M.

    J Nanobiotechnology. 2006 Feb 13;4:2.PMID: 16476163 [PubMed]Related articlesFree article

    2.

    Tumor targeting using canine parvovirus nanoparticles.

    Singh P.

    Curr Top Microbiol Immunol. 2009;327:123-41. Review.PMID: 19198573 [PubMed - indexed for MEDLINE]Related articles

    4.

    Expression and subcellular targeting of canine parvovirus capsid proteins in baculovirus-transduced NLFK cells.

    Gilbert L, Välilehto O, Kirjavainen S, Tikka PJ, Mellett M, Käpylä P, Oker-Blom C, Vuento M.

    FEBS Lett. 2005 Jan 17;579(2):385-92.PMID: 15642348 [PubMed - indexed for MEDLINE]Related articles

    5.

    Assembly of fluorescent chimeric virus-like particles of canine parvovirus in insect cells.

    Gilbert L, Toivola J, Lehtomäki E, Donaldson L, Käpylä P, Vuento M, Oker-Blom C.

    Biochem Biophys Res Commun. 2004 Jan 23;313(4):878-87.PMID: 14706624 [PubMed - indexed for MEDLINE]Related articles

    6.

    The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor.

    Hueffer K, Parker JS, Weichert WS, Geisel RE, Sgro JY, Parrish CR.

    J Virol. 2003 Feb;77(3):1718-26.PMID: 12525605 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.

    Lowin T, Raab U, Schroeder J, Franssila R, Modrow S.

    J Vet Med B Infect Dis Vet Public Health. 2005 Sep-Oct;52(7-8):348-52.PMID: 16316399 [PubMed - indexed for MEDLINE]Related articles

    9.

    Truncated forms of viral VP2 proteins fused to EGFP assemble into fluorescent parvovirus-like particles.

    Gilbert L, Toivola J, Välilehto O, Saloniemi T, Cunningham C, White D, Mäkelä AR, Korhonen E, Vuento M, Oker-Blom C.

    J Nanobiotechnology. 2006 Dec 8;4:13.PMID: 17156442 [PubMed]Related articlesFree article

    10.

    The binding site on the transferrin receptor for the parvovirus capsid, and the effects of altered affinity on cell uptake and infection.

    Goodman LB, Lyi SM, Johnson NC, Cifuente JO, Hafenstein SL, Parrish CR.

    J Virol. 2010 Mar 3. [Epub ahead of print]PMID: 20200243 [PubMed - as supplied by publisher]Related articles

    11.

    Combinations of two capsid regions controlling canine host range determine canine transferrin receptor binding by canine and feline parvoviruses.

    Hueffer K, Govindasamy L, Agbandje-McKenna M, Parrish CR.

    J Virol. 2003 Sep;77(18):10099-105.PMID: 12941920 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Recombination between vaccine and field strains of canine parvovirus is revealed by isolation of virus in canine and feline cell cultures.

    Mochizuki M, Ohshima T, Une Y, Yachi A.

    J Vet Med Sci. 2008 Dec;70(12):1305-14.PMID: 19122396 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Engineering of SV40-based nano-capsules for delivery of heterologous proteins as fusions with the minor capsid proteins VP2/3.

    Inoue T, Kawano MA, Takahashi RU, Tsukamoto H, Enomoto T, Imai T, Kataoka K, Handa H.

    J Biotechnol. 2008 Mar 20;134(1-2):181-92. Epub 2008 Jan 3.PMID: 18243389 [PubMed - indexed for MEDLINE]Related articles

    14.

    Immunodetection of Canine Parvovirus (CPV) in clinical samples by polyclonal antisera against CPV-VP2 protein expressed in Esherichia coli as an antigen.

    Park JS, Choi BK, Vijayachandran LS, Ayyappan V, Chong CK, Lee KS, Kim SC, Choi CW.

    J Virol Methods. 2007 Dec;146(1-2):281-7. Epub 2007 Sep 7.PMID: 17825928 [PubMed - indexed for MEDLINE]Related articles

    15.

    Structures of host range-controlling regions of the capsids of canine and feline parvoviruses and mutants.

    Govindasamy L, Hueffer K, Parrish CR, Agbandje-McKenna M.

    J Virol. 2003 Nov;77(22):12211-21.PMID: 14581558 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Processing of infectious bursal disease virus (IBDV) polyprotein and self-assembly of IBDV-like particles in Hi-5 cells.

    Lee MS, Doong SR, Lai SY, Ho JY, Wang MY.

    Biotechnol Prog. 2006 May-Jun;22(3):763-9.PMID: 16739960 [PubMed - indexed for MEDLINE]Related articles

    17.

    Early steps in cell infection by parvoviruses: host-specific differences in cell receptor binding but similar endosomal trafficking.

    Harbison CE, Lyi SM, Weichert WS, Parrish CR.

    J Virol. 2009 Oct;83(20):10504-14. Epub 2009 Aug 5.PMID: 19656887 [PubMed - indexed for MEDLINE]Related articles

    18.

    Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells.

    Michel PO, Mäkelä AR, Korhonen E, Toivola J, Hedman L, Söderlund-Venermo M, Hedman K, Oker-Blom C.

    J Virol Methods. 2008 Sep;152(1-2):1-5. Epub 2008 Jul 16.PMID: 18598721 [PubMed - indexed for MEDLINE]Related articles

    19.

    Tumor targeting of baculovirus displaying a lymphatic homing peptide.

    Mäkelä AR, Enbäck J, Laakkonen JP, Vihinen-Ranta M, Laakkonen P, Oker-Blom C.

    J Gene Med. 2008 Sep;10(9):1019-31.PMID: 18655234 [PubMed - indexed for MEDLINE]Related articles

    20.

    Delivery of antisense oligonucleotides to leukemia cells by RNA bacteriophage capsids.

    Wu M, Sherwin T, Brown WL, Stockley PG.

    Nanomedicine. 2005 Mar;1(1):67-76.PMID: 17292060 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk